The world’s largest drugmaker, Pfizer, announced third quarter profits that topped expectations, thanks to sales of its pain drugs and a vaccine for pneumonia.
Net income increased four-fold to $3.4 billion, according to Bloomberg.
Pfizer is considering selling or spinning off its nutrition and animal health units to focus on bringing new drugs to market.
Read more at bloomberg.com.